November 12, 2007 - Clinicians at BC Cancer Agency have treated a 72-year-old prostate cancer patient in less than two minutes, using the novel technique called volumetric arc therapy (VMAT).
The VMAT treatment is an advanced form of intensity modulated radiation therapy (IMRT), which has the potential to measurably improve treatment precision by sparing more healthy tissue in addition to making treatments much faster and more comfortable for patients, according to the Varian Medical Systems.

It was made possible by software innovations developed by BC Cancer Agency clinicians together with an advanced medical linear accelerator and beam-shaping accessory from Varian.
Karl Otto, PhD, a medical physicist at the BC Cancer Agency, developed the software algorithm that made it possible for his clinic to deliver the VMAT treatment. "The algorithm is designed to generate highly conformal dose distributions while taking advantage of the specific capabilities of the Varian linear accelerator," he said.

Building on Otto's work, Varian engineers have developed Varian's new RapidArc radiotherapy technology, which was exhibited for the first time at the American Society for Therapeutic Radiology and Oncology (ASTRO) in Los Angeles last week. Varian's RapidArc product for VMAT can deliver intensity-modulated radiotherapy treatments two to eight times faster than was previously possible. It is currently pending FDA clearance and not yet available for sale in the United States.

Unlike more conventional treatment techniques where machines must rotate several times around the patient or make repeated intermittent stops and starts to treat individual fields from a number of different beam angles, VMAT technology reportedly makes it possible to deliver the dose to the entire tumor volume in a single rotation around the patient.

For more information: www.varian.com


Related Content

News | Artificial Intelligence

September 7, 2023 — Paige, a provider of end-to-end digital pathology solutions and clinical AI, has announced a ...

Time September 07, 2023
arrow
News | Radiology Business

July 27, 2023 — Privately-held biotech company TAE Life Sciences has announced that its board of directors has appointed ...

Time July 27, 2023
arrow
News | Image Guided Radiation Therapy (IGRT)

June 7, 2022 — Two-year results from the Dysphagia-Aspiration Related Structures (DARS) trial, which is funded by Cancer ...

Time June 07, 2022
arrow
News | Image Guided Radiation Therapy (IGRT)

May 19, 2022 — Brainlab announced that clinicians at UZ Brussel are the first to treat patients with the company’s new ...

Time May 19, 2022
arrow
News | Radiation Oncology

August 27, 2021 — For decades, the National Comprehensive Cancer Network (NCCN) recommended forgoing post-lumpectomy ...

Time August 27, 2021
arrow
News | Radiation Therapy

June 10, 2020 — A new clinical guideline from the American Society for Radiation Oncology (ASTRO) provides ...

Time June 10, 2020
arrow
News | Radiation Therapy

April 16, 2020 — RefleXion Medical, a therapeutic oncology company pioneering the use of biology-guided radiotherapy ...

Time April 16, 2020
arrow
News | Image Guided Radiation Therapy (IGRT)

February 11, 2020 — Varian announced it has received FDA 510(k) clearance for its Ethos therapy, an Adaptive ...

Time February 11, 2020
arrow
News | Radiology Imaging

December 12, 2019 — Philips and the Regional Medical Center (RMC) announced a strategic 5-year partnership agreement ...

Time December 12, 2019
arrow
News | Radiation Therapy

October 22, 2019 — The American Society for Radiation Oncology (ASTRO) and the American College of Radiology (ACR) ...

Time October 22, 2019
arrow
Subscribe Now